| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &Chief Commercial Officer
1 company
Dreyer Scott is an EVP &Chief Commercial Officer at COLLEGIUM PHARMACEUTICAL, INC. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $4.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sale+OE | 17,600 | $48.17 | $847,855.20 | -7.6% | -22.2% | - | |
| Aug 18, 2025 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sale+OE | 16,389 | $38.21 | $626,171.25 | -13.7% | +18.7% | - | |
| Aug 13, 2025 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sale+OE | 4,861 | $38.03 | $184,880.84 | -4.5% | +18.4% | - | |
| Mar 21, 2025 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sell | 20,808 | $30.03 | $624,794.18 | -8.4% | -0.7% | +17.9% | |
| Mar 14, 2025 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sell | 2,255 | $30.00 | $67,661.05 | -1.8% | +0.5% | +17.1% | |
| Mar 7, 2025 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sell | 5,643 | $30.00 | $169,299.49 | -1.9% | +2.0% | +28.9% | |
| Mar 6, 2025 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sell | 15,387 | $30.00 | $461,671.55 | -10.8% | -1.3% | +25.0% | |
| May 24, 2024 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sale+OE | 108,016 | $33.91 | $3,662,548.45 | -30.6% | +5.2% | -15.7% | |
| Feb 26, 2024 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sell | 10,000 | $36.43 | $364,270.33 | -3.5% | -6.0% | -21.2% | |
| Jan 16, 2024 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sell | 23,560 | $32.28 | $760,519.16 | -17.5% | +8.6% | +1.9% |